Publicación:
Infectious Disease Risk Associated with Contaminated Propofol Anesthesia, 1989–2014

dc.contributor.authorZorrilla-Vaca, Andrés
dc.contributor.authorArevalo, Jimmy J.
dc.contributor.authorEscandón-Vargas, Kevin
dc.contributor.authorSoltanifar, Daniel
dc.contributor.authorMirski, Marek A.
dc.date.accessioned2021-10-28T19:55:01Z
dc.date.available2021-10-28T19:55:01Z
dc.date.issued2017-05-11
dc.description.abstractAdministration of propofol, the most frequently used intravenous anesthetic worldwide, has been associated with several iatrogenic infections despite its relative safety. Little is known regarding the global epidemiology of propofol-related outbreaks and the effectiveness of existing preventive strategies. In this overview of the evidence of propofol as a source of infection and appraisal of preventive strategies, we identified 58 studies through a literature search in PubMed, Embase, and Lilacs for propofol-related infections during 1989–2014. Twenty propofol-related outbreaks have been reported, affecting 144 patients and resulting in 10 deaths. Related factors included reuse of syringes for multiple patients and prolonged exposure to the environment when vials were left open. The addition of antimicrobial drugs to the emulsion has been instituted in some countries, but outbreaks have still occurred. There remains a lack of comprehensive information on the effectiveness of measures to prevent future outbreaks.eng
dc.format.extent12 p.spa
dc.format.mimetypeapplication/pdfspa
dc.identifier.urihttps://repositorio.fucsalud.edu.co/handle/001/1874
dc.language.isoengspa
dc.publisherAtlanta GA: Centers for Disease Control and Preventionspa
dc.publisher.placeEstados Unidosspa
dc.relation.citationendpage992spa
dc.relation.citationissue6spa
dc.relation.citationstartpage981spa
dc.relation.citationvolume22spa
dc.relation.ispartofEmergent Infectious Disease CDC ISSN:1080-6059 Vol.22 Núm. 6 (2016)
dc.relation.ispartofjournalEmergent Infectious Disease CDCspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/spa
dc.sourcehttps://wwwnc.cdc.gov/eid/article/22/6/15-0376_articlespa
dc.subject.proposalEnfermedades infecciosasspa
dc.subject.proposalAnestesiaspa
dc.subject.proposalAnestésicos generalesspa
dc.subject.proposalPropofol - Efectos adversosspa
dc.titleInfectious Disease Risk Associated with Contaminated Propofol Anesthesia, 1989–2014eng
dc.typeArtículo de revistaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.redcolhttps://purl.org/redcol/resource_type/WPspa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublication

Archivos

Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Infectious Disease Risk.pdf
Tamaño:
244.65 KB
Formato:
Adobe Portable Document Format
Descripción:
Artículo
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
15.06 KB
Formato:
Item-specific license agreed upon to submission
Descripción:

Colecciones